The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Aged 74. Hopefully he'll be aware of the related party relationship laws. No news yet on that front.
Lots more news to come....
The company had better get this sorted pronto with suspension due next week. If Wicks is involved in one of the undisclosed related party issues it will probably rule him out of consideration. Too risky a punt now until there is more clarity here.
As I've always claimed here, the company operates as if a private vehicle and now with the unreported related party transactions issue, it is a proof of the pudding. This has probably been going on here for a number of years so a LSE investigation would be correctly due to look at each transaction to determine for whose benefit they were as if not primarily for the company then the directors would be culpable. The company is now Un-investable until the answers are known and all people brought to account.
If the current board members cannot retrieve things sharpish then Administrators might be in order to secure whatever value remains here for the creditors.
This company has a few loyal shareholders still ie. Webley, but he's wealthy so can afford to lose a chunk of his investment money without affecting things much. For the rest, a modest speculative punt this remains, live in hope not expectation with this one.
At least investors had a few days to sell up after the CEO departure as the red flags were certainly waving at that point.
A rather poor show from the board members involved over recent years. Still taking a nice salary each I would imagine though. I had always hoped to be able to re-invest in this company one day having sold my stake at circa. 80p but since Paul Brett departed things have fallen apart somewhat.
No news yet on the matter.
This company always seems to flatter to deceive if that's not being too harsh.
Impression is of a private company disguising itself as a public company as run on private lines.
Suggest the next interview for a CEO is done by Alan Sugar as he usually gets things right.
Cannot afford to drag out the uncertainty much longer.
The bluntness of the RNS leads me to suspect that he found something not strictly kosher (a non kosher savaloy?) hence the need to make a report or disclosure to officialdom and the company might be unable to give more insight at the present time. The board would have expected the share price to dive on the announcement but couldn't offer a sweetener to go with it. Maybe a suspension at 7am tomorrow.
Extraordinary news today and the company needs to let the market know asap what's happening. If bad news, the share price will correct to a lower value and if nothing bad then it should rise back upwards. Being dumb is not an option here for the sake of the long suffering shareholders.
The Auditors report of Shipleys LLP on 21 October 2022 includes a mention of there being a material uncertainty of the going concern which is a bit of warning flag. Hopefully a take-over happens sooner rather than later.
Told me he has a 8p take-over price target on this one
Nice to read some straightforward and thoughtful comments.
A long way from the robotic posts made by someone when this company was buying its own shares on a daily basis.
Little interest in this company currently, the jury on the new boss is out.
With the SP down 80% from the high, surely a pharma with the resources would see SAR as an opportunistic buy? A bid of say 250p would be hard for the Board to dismiss given the obstacles and costs that lay ahead and the prospect of getting any more placings away at a half-decent price preventing further dilution for current shareholders. I think now is a perfect time for a third party to make a move.